Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/10/12 → 5/30/15 |
27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- Nickl, Nicholas (PI)